LivaNova (LIVN) Amortization of Deferred Charges (2019 - 2026)
LivaNova (LIVN) posted Amortization of Deferred Charges of $4.8 million for Q1 2026, up 222.08% sequentially from -$3.9 million in Q4 2025, and down 15.43% YoY from $5.7 million in Q1 2025.
LivaNova (LIVN) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
LivaNova has reported Amortization of Deferred Charges for 8 years, with the latest figure at $4.8 million in Q1 2026.
- Quarterly Amortization of Deferred Charges fell 15.43% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 million (up 29.71% YoY) and the FY2025 annual result came in at $13.4 million, up 51.43% from the prior year.
- Amortization of Deferred Charges advanced to $4.8 million in Q1 2026 per LIVN's latest filing, from -$3.9 million in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $5.9 million in Q3 2025 and troughed at -$6.9 million in Q4 2024.
- A 5-year average of $3.5 million and a median of $4.9 million in 2023 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges jumped 89.18% in 2023, then sank 242.79% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $4.9 million in 2022, then retreated by 2.69% to $4.8 million in 2023, then tumbled by 242.79% to -$6.9 million in 2024, then soared by 42.72% to -$3.9 million in 2025, then jumped by 222.08% to $4.8 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $4.8 million, -$3.9 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.90 Mn |
| Jun 30, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.80 Mn |
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | -3.93 Mn |
| Dec 31, 2025 | -3.93 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Sep 30, 2025 | 5.90 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | -6.86 Mn |
| Dec 31, 2024 | -6.86 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | 4.90 Mn |
| Mar 31, 2024 | 4.90 Mn |